Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Florence Ouedraogo"'
Autor:
Marc Christian Tahita, Paul Sondo, Berenger Kabore, Hamidou Ilboudo, Toussaint Rouamba, Hyacinthe Sanou, Kadija Ouédraogo, Adélaïde Compaoré, Palpouguini Lompo, Florence Ouedraogo, Seydou Sawadogo, Karim Derra, Yabré Edmond Sawadogo, Athanase M. Somé, Macaire Nana, Hermann Sorgho, Maminata Traore-Coulibaly, Quique Bassat, Halidou Tinto
Publikováno v:
Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Background Malaria infection during pregnancy (MIP) is not only deleterious to the woman, but it also puts her fetus at increased risk of adverse outcomes, such as preterm delivery, low birth weight, and intrauterine growth retardation. Addi
Externí odkaz:
https://doaj.org/article/3adcd5ea8ef64051a50e735e8c0ed257
Autor:
Paul Sondo, Toussaint Rouamba, Marc Christian Tahita, Karim Derra, Berenger Kabore, Yssimini Nadège Guillène Tibiri, Hyacinthe Abd-El Latif Faïçal Kabore, So-vii Franck Hien, Florence Ouedraogo, Adama Kazienga, Hamidou Ilboudo, Eli Rouamba, Thiery Lefevre, Halidou Tinto
Publikováno v:
PLoS ONE, Vol 18, Iss 6 (2023)
Seasonal Malaria chemoprevention (SMC) is one of the large-scale life-saving malaria interventions initially recommended for the Sahel subregion, including Burkina Faso and recently extended to other parts of Africa. Initially, SMC was restricted to
Externí odkaz:
https://doaj.org/article/8f18ea808e534ee3b30d680c8bda473b
Autor:
Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans, Amos Kotey, Pascale Vandoolaeghe, Mark Cullinane, Magali Traskine, Florence Ouedraogo, David Sambian, Marc Lievens, Marc Christian Tahita, Erik Jongert, Palpouguini Lompo, Ali Idriss, Dorota Borys, Sayouba Ouedraogo, Frank Prempeh, Lode Schuerman, Hermann Sorgho, Tsiri Agbenyega
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1464-1470 (2020)
RTS,S/AS01E malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impact of RTS,S/AS01E when implemented in the Expanded Program of Immunization, infants 8–12 weeks old
Externí odkaz:
https://doaj.org/article/fc88a75214814b4181d957a8ec82fef3
Autor:
Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Amanda Leach, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans, Louis Arnaud Nana, Amos Kotey, Pascale Vandoolaeghe, Florence Ouedraogo, David Sambian, Marc Lievens, Marc Christian Tahita, Theresa Rettig, Erik Jongert, Palpouguini Lompo, Ali Idriss, Dorota Borys, Sayouba Ouedraogo, Frank Prempeh, Md Ahsan Habib, Lode Schuerman, Hermann Sorgho, Tsiri Agbenyega
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1489-1500 (2018)
The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-ty
Externí odkaz:
https://doaj.org/article/1161027a5eef47e6be6997a269ed1613
Autor:
Prabin Dahal, Karim Derra, Eli Rouamba, Maminata Traore, Hamidou Ilboudo, Cheick Saïd Compaoré, Athanase M Some, Macaire Nana, Paul Sondo, Florence Ouedraogo, Berenger Kaboré, Innocent Valea, Halidou Tinto, Coulibaly, Hermann Sorgho, Estelle Aïssa Bambara, Marc Christian Tahita, Toussaint Rouamba, Edmond Yabré Sawadogo
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-10 (2021)
Trials
Trials
Background Malaria and malnutrition represent major public health concerns worldwide especially in Sub-Sahara Africa. Despite implementation of seasonal malaria chemoprophylaxis (SMC), an intervention aimed at reducing malaria incidence among childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b700466e08fd3b98b64e89c85a0db9ea
https://doaj.org/article/2ad7b0c61bb042b5a72fb8cf54f4634a
https://doaj.org/article/2ad7b0c61bb042b5a72fb8cf54f4634a
Autor:
Mehreen S Datoo, Hamtandi Magloire Natama, Athanase Somé, Duncan Bellamy, Ousmane Traoré, Toussaint Rouamba, Marc Christian Tahita, N Félix André Ido, Prisca Yameogo, Daniel Valia, Aida Millogo, Florence Ouedraogo, Rachidatou Soma, Seydou Sawadogo, Faizatou Sorgho, Karim Derra, Eli Rouamba, Fernando Ramos-Lopez, Matthew Cairns, Samuel Provstgaard-Morys, Jeremy Aboagye, Alison Lawrie, Rachel Roberts, Innocent Valéa, Hermann Sorgho, Nicola Williams, Gregory Glenn, Louis Fries, Jenny Reimer, Katie J Ewer, Umesh Shaligram, Adrian V S Hill, Halidou Tinto
Publikováno v:
The Lancet. Infectious diseases. 22(12)
Malaria is a leading cause of morbidity and mortality worldwide. We previously reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified goal of 75% or greater efficacy over 12 months in the target population of Afric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9960ccb7d631125bcae3e3be558a34f2
https://pubmed.ncbi.nlm.nih.gov/36087586
https://pubmed.ncbi.nlm.nih.gov/36087586
Autor:
Frank Prempeh, Johan Vekemans, Effua Usuf, Samuel Adjei, Dorota Borys, Mark Cullinane, Ali Idriss, Harry Owusu Boateng, Pascale Vandoolaeghe, Innocent Valea, Athanase M Some, Ousmane Traore, Amos Kotey, Marc Christian Tahita, Erik Jongert, Hermann Sorgho, Sayouba Ouedraogo, Marc Lievens, Lode Schuerman, Magali Traskine, Tsiri Agbenyega, David Sambian, Daniel Ansong, Halidou Tinto, Patrick Buabeng, Palpouguini Lompo, Florence Ouedraogo
Publikováno v:
Human Vaccines & Immunotherapeutics. 16:1464-1470
RTS,S/AS01E malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impact of RTS,S/AS01E when implemented in the Expan...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6907f153881dc187ca11199cf172ab0d
https://doi.org/10.1080/21645515.2019.1695457
https://doi.org/10.1080/21645515.2019.1695457
Autor:
Florence Ouedraogo, Reshma Kailath, Amy Flaxman, Andres Noe, Rachidatou Soma, Fernando Ramos Lopez, Katie J. Ewer, Eli Rouamba, Umesh Shaligram, Jenny M. Reimer, Toussaint Rouamba, Federica Cappuccini, Ousmane Traore, Athanase M Some, Prisca Yameogo, Matthew Cairns, M Datoo, Daniel Valia, Benedict O. Orindi, Seydou Sawadogo, Sean C. Elias, Karim Derra, D Bellamy, Faizatou Sorgho, Magloire H Natama, Adrian V. S. Hill, E Mukhopadhyay, Hermann Sorgho, Innocent Valea, Alison M. Lawrie, Moubarak Tegneri, Rachel Roberts, Gregory M. Glenn, Halidou Tinto, Louis Fries, Nicola Williams
Publikováno v:
Lancet, 397 (10287
Stalled progress in controlling Plasmodium falciparum malaria highlights the need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine candidate to date, demonstrated 56% efficacy over 12 months in African children.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ce074b426a190ef5d943b4c759db00
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/323431
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/323431
Autor:
Paul Sondo, Marc Christian TAHITA, Toussaint ROUAMBA, Karim DERRA, Berenger KABORE, Cheick Saïd COMPAORE, Florence OUEDRAOGO, Eli ROUAMBA, Hamidou ILBOUDO, Estelle BAMBARA, Macaire NANA, Edmond SAWADOGO, Herman SORGHO, Athanase Mwinessobaonfou SOME, Innocent VALEA, Prabin DAHAL, Maminata TRAORE/COULIBALY, Halidou TINTO
• Background: Malaria and malnutrition represent major public health concerns worldwide especially in Sub-Sahara Africa. Despite implementation of Seasonal Malaria Chemoprophylaxis (SMC), an intervention aimed at reducing malaria incidence among ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c3af37e9f54d3bf00d8e0e36a1dfc8e
https://doi.org/10.21203/rs.3.rs-54198/v1
https://doi.org/10.21203/rs.3.rs-54198/v1
Autor:
Karim Derra, Innocent Valea, Reshma Kailath, Katie J. Ewer, Jenny M. Reimer, Fernando Ramos-Lopez, Moubarak Tegneri, Federica Cappuccini, Benedict O. Orindi, Halidou Tinto, Seydou Sawadogo, Rachel Roberts, Toussaint Rouamba, Hermann Sorgho, Daniel Valia, Gregory M. Glenn, Florence Ouedraogo, D Bellamy, Louis Fries, Eli Rouamba, Faizatou Sorgho, Nicola Williams, Athanase M Some, Matthew Cairns, M Datoo, Amy Flaxman, Ousmane Traore, Adrian V. S. Hill, Sean C. Elias, E Mukhopadhyay, Prisca Yameogo, Umesh Shaligram, Alison M. Lawrie, Andres Noe, Rachidatou Soma, Hamtandi Magloire Natama
Publikováno v:
SSRN Electronic Journal.
Background: Stalled progress in controlling Plasmodium falciparum malaria highlights the need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine candidate to date, demonstrated 55·8% (97·5% confidence interval [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6526db818d14bd673ec1471f530a2d3a
https://doi.org/10.2139/ssrn.3830681
https://doi.org/10.2139/ssrn.3830681